Calidi Biotherapeutics (CLDI) Other Non Operating Income (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Other Non Operating Income of $135000.0 for Q4 2025, up 1587.5% year-over-year from $8000.0 in Q4 2024, and up 650.0% quarter-over-quarter from $18000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Other Non Operating Income (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at $135000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 1587.5% year-over-year to $135000.0; the TTM figure through Dec 2025 stood at $121000.0 (up 1244.44% YoY), while the FY2025 annual figure was $121000.0, up 1244.44% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $135000.0, up from $18000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $135000.0 in Q4 2025, with the low at -$22000.0 in Q4 2023.
- The 4-year median for Other Non Operating Income is -$6500.0 (2023), against an average of $5000.0.
- Peak annual rise in Other Non Operating Income reached 1587.5% in 2025, while the deepest fall reached 320.0% in 2025.
- Calidi Biotherapeutics' Other Non Operating Income stood at -$13000.0 in 2022, then tumbled by 69.23% to -$22000.0 in 2023, then surged by 136.36% to $8000.0 in 2024, then soared by 1587.5% to $135000.0 in 2025.
- Business Quant data shows CLDI's Other Non Operating Income at $135000.0 in Q4 2025, $18000.0 in Q3 2025, and -$22000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | 4,000.00 |